The Oncology Institute, Inc. TOI Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s operating lease liabilities (total)?
- The Oncology Institute, Inc. (TOI) reported operating lease liabilities (total) of $26.25M in Q1 2026.
- How has The Oncology Institute, Inc.'s operating lease liabilities (total) changed year-over-year?
- The Oncology Institute, Inc.'s operating lease liabilities (total) decreased by 7.6% year-over-year, from $28.41M to $26.25M.
- What is the long-term trend for The Oncology Institute, Inc.'s operating lease liabilities (total)?
- Over 3 years (2022 to 2025), The Oncology Institute, Inc.'s operating lease liabilities (total) has grown at a -1.6% compound annual growth rate (CAGR), from $27.56M to $26.29M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.